Seamless study of Coriandrum Sativum Buffer Extract [CSBE] on its Therapeutical Applications

The existent study pacts with the Coriandrum Sativum Buffer Extract [CSBE] extraction,preliminary screening, depiction and the role of CSBE on microbial cultures, packed RBC and humanplasma. Coriandrum Sativum seeds were subjected to Soxhlet extraction using phosphate buffer and thefinal obtained extract was named as Coriandrum Sativum Buffer Extract [CSBE]. CSBE shows thewithholding of terpenoids, glycosides, saponins, flavonoids, carbohydrates, steroids and lipids when itsubjected for preliminary screening. CSBE proves the presence of many micro and macro molecules in theextract, as it elute 6 peaks and 10 peaks when we subjected for HPLC and GC-MS respectively.Unfortunately, CSBE does not show any role on microbial cultures as it unable to exhibit zone ofinhibition when it incubated with E.coli and S.aureus. Furthermore, CSBE does not show any activitywhen it treated with Platelet Rich Plasma [PRP] and Platelet Poor Plasma [PPP] during the analysisplasma re-calcification time assay. But, CSBE demonstrate anti-platelet activity for ADP receptor as itinhibits the platelet aggregation by 68% at the concentration of 300µg. In addition, CSBE exhibit nontoxic property as it unable to rupture the membrane of packed RBC.